Hinne A. Rakhorst

Hinne A. Rakhorst

Auto-generated profile, based on publicly available information

Hinne A. Rakhorst

Dept Plastic Surgery, Universitair Medisch Centrum Groningen, Groningen, the Netherlands

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in JAMA Oncology
Verified
Journal Article
Open access
PDF file
MBMintsje de Boer
Mintsje de Boer
FLFlora E. van Leeuwen
Flora E. van Leeuwen
MHMichael Hauptmann
Michael Hauptmann
LOLucy I. H. Overbeek
Lucy I. H. Overbeek
JBJan Paul de Boer
Jan Paul de Boer
Daphne D. De JongDaphne D. De Jong
Daphne D. De Jong
Since the introduction of breast implants in the 1960s, their safety has been debated extensively, even resulting in a temporary ban (1992-2006) on silicone-gel implants for cosmetic indications by the US Food and Drug Administration (FDA).1 However, consistent associations of silicone breast implants with adverse events, such as breast cancer, autoimmune diseases, and connective tissue diseases have not been substantiated, as recently underlined by 2 meta-analyses.2,3 The risk for anaplastic large-cell lymphoma (ALCL) in the breast in relation to breast implants was not discussed in these studies.2,3

1 March 2019 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
DCDavid J. Collett
David J. Collett
HRHinne Rakhorst
Hinne Rakhorst
PLPeter Lennox
Peter Lennox
MMMark Magnusson
Mark Magnusson
RCRodney Cooter
Rodney Cooter
ADAnand Deva
Anand Deva
Background: With breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) now accepted as a unique (iatrogenic) subtype of ALCL directly associated with textured breast implants, we are now at a point where a sound epidemiologic profile and risk estimate are required. The aim of this article is to provide a comprehensive and up-to-date global review of the available epidemiologic data and literature relating to the incidence, risk, and prevalence of BIA-ALCL. Methods: All current literature relating to the epidemiology of BIA-ALCL was reviewed. Barriers relating to sound epidemiologic study were identified, and trends relating to geographical distribution, prevalence of breast implants, and implant characteristics were analyzed. Results: Significant barriers exist to the accurate estimate of both the number of women with implants (denominator) and the number of cases of BIA-ALCL (numerator), including poor registries, underreporting, lack of awareness, cosmetic tourism, and fear of litigation. The incidence and risk of BIA-ALCL have increased dramatically from initial reports of 1 per million to current estimates of 1/2,832, and is largely dependant on the “population” (implant type and characteristics) examined and increased awareness of the disease. Conclusions: Although many barriers stand in the way of calculating accurate estimates of the incidence and risk of developing BIA-ALCL, steady progress, international registries, and collegiality between research teams are for the first time allowing early estimates. Most striking is the exponential rise in incidence over the last decade, which can largely be explained by the increasingly specific implant subtypes examined—driven by our understanding of the pathologic mechanism of the disease. High-textured high-surface area implants (grade 4 surface) carry the highest risk of BIA-ALCL (1/2,832).

1 March 2019 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
MMMark R. Magnusson
Mark R. Magnusson
RCRod D. Cooter
Rod D. Cooter
HRHinne Rakhorst
Hinne Rakhorst
PMPatricia A. McGuire
Patricia A. McGuire
WAWilliam P. Adams
William P. Adams
ADAnand K. Deva
Anand K. Deva
Summary: The link between breast implants and systemic disease has been reported since the 1960s. Although many studies have looked at either supporting or refuting its existence, the issue still persists and has now been labeled “breast implant illness.” The rise of patient advocacy and communication through social media has led to an increasing number of presentations to plastic surgeons. This article summarizes the history of breast implants and systemic disease, critically analyzes the literature (and any associated deficiencies), and suggests a way forward through systematic scientific study.

1 June 2018 in Plastic and Reconstructive Surgery
Verified
Journal Article
Closed access
PDF file
ABAlexandra Bucknor
Alexandra Bucknor
PKParisa Kamali
Parisa Kamali
NPNicole Phillips
Nicole Phillips
IMIrene Mathijssen
Irene Mathijssen
HRHinne Rakhorst
Hinne Rakhorst
HFHeather Furnas
Heather Furnas
Background: Previous research has highlighted the gender-based disparities present throughout the field of surgery. This study aims to evaluate the breadth of the issues facing women in plastic surgery, worldwide. Methods: A systematic scoping review was undertaken from October of 2016 to January of 2017, with no restrictions on date or language. A narrative synthesis of the literature according to themed issues was developed, together with a summary of relevant numeric data. Results: From the 2247 articles identified, 55 articles were included in the analysis. The majority of articles were published from the United States. Eight themes were identified, as follows: (1) workforce figures; (2) gender bias and discrimination; (3) leadership and academia; (4) mentorship and role models; (5) pregnancy, parenting, and childcare; (6) relationships, work-life balance, and professional satisfaction; (7) patient/public preference; and (8) retirement and financial planning. Despite improvement in numbers over time, women plastic surgeons continue to be underrepresented in the United States, Canada, and Europe, with prevalence ranging from 14 to 25.7 percent. Academic plastic surgeons are less frequently female than male, and women academic plastic surgeons score less favorably when outcomes of academic success are evaluated. Finally, there has been a shift away from overt discrimination toward a more ingrained, implicit bias, and most published cases of bias and discrimination are in association with pregnancy. Conclusions: The first step toward addressing the issues facing women plastic surgeons is recognition and articulation of the issues. Further research may focus on analyzing geographic variation in the issues and developing appropriate interventions.

1 August 2007 in Annals of Plastic Surgery
Verified
Journal Article
Closed access
SHStefan O. P. Hofer
Stefan O. P. Hofer
TDTim H. C. Damen
Tim H. C. Damen
MMMarc A. M. Mureau
Marc A. M. Mureau
HRHinne A. Rakhorst
Hinne A. Rakhorst
NRNathalie A. Roche
Nathalie A. Roche
The purpose of this study was to critically evaluate the perioperative complications for deep inferior epigastric perforator (DIEP) flap breast reconstruction. From February 2002 until February 2006, 175 consecutive abdominal free tissue breast reconstructions were performed in 131 patients. Perioperative risk factors and complications were evaluated for the entire group. Data analysis was performed to compare subsequent chronologic groups for a learning curve effect. In 159 cases (90.9%) a DIEP flap could be raised. In 13 cases (7.4%), a mini-TRAM flap and in 3 cases (1.7%) a regular free TRAM flap was harvested. A learning curve was found showing a risk for flap complications in the first 30 DIEP flaps of 40% and in flaps 31 to 175 of 13.8% (P < 0.012). Microsurgical revision rate was 4% (n = 7), with a total flap failure rate of 0.6% (n = 1). Partial flap failure rate was 8.6% (n = 15), which was solved by debridement, medial advancement, and direct closure in 6.8% (n = 12) and latissimus dorsi flap transposition in 1.8% (n = 3). Multivariate analysis showed no significant influence of risk factors on development of postoperative flap complications. DIEP flap breast reconstruction is an excellent method, with limited donor-site morbidity. A definite learning curve was reflected in a larger number of flap complications in the beginning of our series.

1 October 2017 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
HRHinne A. Rakhorst
Hinne A. Rakhorst
MMMarc A M Mureau
Marc A M Mureau
RCRodney D. Cooter
Rodney D. Cooter
JMJohn McNeil
John McNeil
MHMiranda van Hooff
Miranda van Hooff
IMIrene M.J. Mathijssen
Irene M.J. Mathijssen